CCM
Cinctive Capital Management’s Boston Scientific BSX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-103,559
| Closed | -$10.4M | – | 363 |
|
2025
Q1 | $10.4M | Buy |
+103,559
| New | +$10.4M | 0.8% | 26 |
|
2024
Q4 | – | Sell |
-175,563
| Closed | -$14.7M | – | 345 |
|
2024
Q3 | $14.7M | Sell |
175,563
-73,431
| -29% | -$6.15M | 0.8% | 25 |
|
2024
Q2 | $19.2M | Sell |
248,994
-40,287
| -14% | -$3.1M | 0.91% | 17 |
|
2024
Q1 | $19.8M | Buy |
289,281
+108,460
| +60% | +$7.43M | 0.92% | 21 |
|
2023
Q4 | $10.5M | Buy |
+180,821
| New | +$10.5M | 0.69% | 32 |
|
2023
Q3 | – | Sell |
-237,146
| Closed | -$12.8M | – | 358 |
|
2023
Q2 | $12.8M | Sell |
237,146
-119,714
| -34% | -$6.48M | 0.43% | 57 |
|
2023
Q1 | $17.9M | Buy |
356,860
+214,415
| +151% | +$10.7M | 0.59% | 32 |
|
2022
Q4 | $6.59M | Sell |
142,445
-313,924
| -69% | -$14.5M | 0.32% | 88 |
|
2022
Q3 | $17.7M | Buy |
456,369
+21,508
| +5% | +$833K | 0.74% | 15 |
|
2022
Q2 | $16.2M | Buy |
434,861
+120,901
| +39% | +$4.51M | 0.68% | 16 |
|
2022
Q1 | $13.9M | Buy |
313,960
+180,426
| +135% | +$7.99M | 0.52% | 31 |
|
2021
Q4 | $5.67M | Buy |
+133,534
| New | +$5.67M | 0.25% | 124 |
|
2021
Q3 | – | Sell |
-141,932
| Closed | -$6.07M | – | 510 |
|
2021
Q2 | $6.07M | Sell |
141,932
-264,442
| -65% | -$11.3M | 0.28% | 101 |
|
2021
Q1 | $15.7M | Buy |
+406,374
| New | +$15.7M | 0.96% | 6 |
|
2020
Q3 | – | Sell |
-99,769
| Closed | -$3.5M | – | 284 |
|
2020
Q2 | $3.5M | Sell |
99,769
-16,031
| -14% | -$563K | 0.4% | 95 |
|
2020
Q1 | $3.78M | Buy |
115,800
+8,418
| +8% | +$275K | 0.84% | 32 |
|
2019
Q4 | $4.86M | Buy |
+107,382
| New | +$4.86M | 0.51% | 89 |
|